This Article Full Text Full Text (PDF) Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Appleyard, S. M. Articles by Low, M. J. Search for Related Content PubMed PubMed Citation Articles by Appleyard, S. M. Articles by Low, M. J. Pubmed/NCBI databases Gene GEO Profiles HomoloGene UniGene Compound via MeSH Substance via MeSH Hazardous Substances DB GLUCOSE NALOXONE

A Role for the Endogenous Opioid ß-Endorphin in Energy Homeostasis

Vollum Institute, Oregon Health and Science University (S.M.A., M.H., A.A.B., R.D.C., M.J.L.), Portland, Oregon 97239; Instituto de Investigaciones en Ingeniería Genética y Biología Molecular (CONICET) and Department of Physiology, Molecular, and Cellular Biology, Universidad de Buenos Aires (J.I.Y., M.R.), Buenos Aires 1428, Argentina

Address all correspondence and requests for reprints to: Dr. Malcolm J. Low, Vollum Institute, Oregon Health and Science University, L474, Portland, Oregon 97201. E-mail: low{at}ohsu.edu.

Proopiomelanocortin (POMC) neurons in the hypothalamus are direct targets of the adipostatic hormone leptin and contribute to energy homeostasis by integrating peripheral and central information. The melanocortin and ß-endorphin neuropeptides are processed from POMC and putatively coreleased at axon terminals. Melanocortins have been shown by a combination of pharmacological and genetic methods to have inhibitory effects on appetite and body weight. In contrast, pharmacological studies have generally indicated that opioids stimulate food intake. Here we report that male mice engineered to selectively lack ß-endorphin, but that retained normal melanocortin signaling, were hyperphagic and obese. Furthermore, ß-endorphin mutant and wild-type mice had identical orexigenic responses to exogenous opioids and identical anorectic responses to the nonselective opioid antagonist naloxone, implicating an alternative endogenous opioid tone to ß-endorphin that physiologically stimulates feeding. These genetic data indicate that ß-endorphin is required for normal regulation of feeding, but, in contrast to earlier reports suggesting opposing actions of ß-endorphin and melanocortins on appetite, our results suggest a more complementary interaction between the endogenously released POMC-derived peptides in the regulation of energy homeostasis.

This article has been cited by other articles:

				Y. C. L. Tung, D. Rimmington, S. O'Rahilly, and A. P. Coll Pro-Opiomelanocortin Modulates the Thermogenic and Physical Activity Responses to High-Fat Feeding and Markedly Influences Dietary Fat Preference Endocrinology, November 1, 2007; 148(11): 5331 - 5338. [Abstract] [Full Text] [PDF]

				L. E. Pritchard and A. White Neuropeptide Processing and Its Impact on Melanocortin Pathways Endocrinology, September 1, 2007; 148(9): 4201 - 4207. [Abstract] [Full Text] [PDF]

				J. L. Smart, V. Tolle, V. Otero-Corchon, and M. J. Low Central Dysregulation of the Hypothalamic-Pituitary-Adrenal Axis in Neuron-Specific Proopiomelanocortin-Deficient Mice Endocrinology, February 1, 2007; 148(2): 647 - 659. [Abstract] [Full Text] [PDF]

				L. Huo, H. J. Grill, and C. Bjorbaek Divergent Regulation of Proopiomelanocortin Neurons by Leptin in the Nucleus of the Solitary Tract and in the Arcuate Hypothalamic Nucleus Diabetes, March 1, 2006; 55(3): 567 - 573. [Abstract] [Full Text] [PDF]

				A. Tabarin, Y. Diz-Chaves, M. d. C. Carmona, B. Catargi, E. P. Zorrilla, A. J. Roberts, D. V. Coscina, S. Rousset, A. Redonnet, G. C. Parker, et al. Resistance to Diet-Induced Obesity in {micro}-Opioid Receptor-Deficient Mice: Evidence for a "Thrifty Gene" Diabetes, December 1, 2005; 54(12): 3510 - 3516. [Abstract] [Full Text] [PDF]

				M. Baker, N. Gaukrodger, B. M. Mayosi, H. Imrie, M. Farrall, H. Watkins, J. M.C. Connell, P. J. Avery, and B. Keavney Association Between Common Polymorphisms of the Proopiomelanocortin Gene and Body Fat Distribution: A Family Study Diabetes, August 1, 2005; 54(8): 2492 - 2496. [Abstract] [Full Text] [PDF]

				B. P. Meij, R. H. van der Vlugt-Meijer, T. S. G. A. M. van den Ingh, G. Flik, and A. Rijnberk Melanotroph Pituitary Adenoma in a Cat with Diabetes Mellitus Vet. Pathol., January 1, 2005; 42(1): 92 - 97. [Abstract] [Full Text] [PDF]

				E. Savontaus, T. L. Breen, A. Kim, L. M. Yang, S. C. Chua Jr., and S. L. Wardlaw Metabolic Effects of Transgenic Melanocyte-Stimulating Hormone Overexpression in Lean and Obese Mice Endocrinology, August 1, 2004; 145(8): 3881 - 3891. [Abstract] [Full Text] [PDF]

				A. Sahu Minireview: A Hypothalamic Role in Energy Balance with Special Emphasis on Leptin Endocrinology, June 1, 2004; 145(6): 2613 - 2620. [Abstract] [Full Text] [PDF]

				T. M. Mizuno, K. A. Kelley, G. M. Pasinetti, J. L. Roberts, and C. V. Mobbs Transgenic Neuronal Expression of Proopiomelanocortin Attenuates Hyperphagic Response to Fasting and Reverses Metabolic Impairments in Leptin-Deficient Obese Mice Diabetes, November 1, 2003; 52(11): 2675 - 2683. [Abstract] [Full Text] [PDF]